Yi Xia

Also affiliated with Sun Yat-sen University Cancer Center, Jiangsu Province Hospital, CTI BioPharma (Italy), Nanjing Medical University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “814 | FIRST‐LINE SELINEXOR IN COMBINATION WITH R‐CHOP FOR EBV‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (XPLORE): A SINGLE‐ARM, PHASE IB/II Trial”.

814 | FIRST‐LINE SELINEXOR IN COMBINATION WITH R‐CHOP FOR EBV‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (XPLORE): A SINGLE‐ARM, PHASE IB/II Trial

Hematological Oncology(2025)10.1002/hon.70096_814

N/A

0DataRank · unranked

0 citations

Rong Tao, Yi Xia, Wenming Zhang, Chen Liu, Shiyu Jiang +8 more